Loading…
NXL
Nexalin Technology, Inc.
NASDAQ· Healthcare· Medical Devices· CUSIP 65345B201
$0.25-1.88%Price as of Aug 29, 18:45 UTC · updated once a day, after the close
Key metrics
- Market cap
- $213.88K
- P/E
- —
- Forward P/E
- —
- P/B
- 3.6x
- Dividend yield
- —
- Payout
- —
- EPS
- -$13.53
- ROE
- -240.25%
- Profit margin
- 0.00%
- Revenue growth
- -82.80%
- Beta
- 4.04
- 52-week high
- $2.00
- 52-week low
- $0.22
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -86.5% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $16.74 | $82.80 | $12.15 | $22.47 | |
| P/S | 32.6x | 38.1x | 217.6x | 27.2x | 4.1x |
| P/B | 2.0x | 3.1x | 10.0x | 0.9x | 1.0x |
| EPS | -$15.00 | -$24.90 | -$18.90 | -$9.00 | |
| Profit margin | -3461.66% | -2725.76% |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| GCTKGlucotrack, Inc. | $0.28 | 0.0x | — | — | -620.63% | $225.08K |
| ARTLArtelo Biosciences Inc | $0.66 | — | 0.6x | — | -705.71% | $363.01K |
| VBIOValion Bio, Inc. | $0.12 | — | 0.1x | — | -459.52% | $107.31K |
| VTAKCatheter Precision, Inc. | $0.20 |
About the company
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
- 8
- Houston, United States
Company description provided by Yahoo Finance.